CSI Market
Sign In | Register

Altimmune inc (ALT) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access ALT quarterly Cash Flow →
Changes in quarterly cash flow trends offer perspective on how Altimmune inc funds operations, investments, and shareholder returns.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-88.09
Depreciation & amortization0.11
Amortization of Other Assets0.36
Increase (Decrease) in Deferred Revenue0.00
Impairment of Long-Lived Assets to be Disposed of0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
Research and Development in Process0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation16.08
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), Unrealized0.16
Provision And Recovery For Doubtful Accounts-
Gain Loss On Derivative Instruments Net Pretax-
Otherincome Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation-
Debt Securities Unrealized Gain Loss-
Debt Discount And Deferred Financing Cost Accretion-
Debt Discount Accretion-
Increase Decrease In Income Taxes And Tax Incentive Receivable2.74
Income taxes-0.68
Unrealized Gain (Loss) on Derivatives0.00
Increase (Decrease) in Accounts Receivable-0.68
Increase (Decrease) in Accounts Payable2.51
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities2.39
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.20
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-2.22
Discontinued operations0.00
Net Cash flow from Operating Activities-67.54
Investing Activities
Capital Expenditures-0.01
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Available-for-sale Securities152.99
Payments to Acquire Available-for-sale Securities, Debt-285.45
Real Estate Investments0.00
Proceeds From Sale Of Assets Held For Sale-
Refund Of Cash Held In Escrow-
Decrease in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Cash Acquired from Acquisition0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-132.47
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-1.08
Long-term debt - borrowings35.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock174.07
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.71
Proceeds From Issuance Of Common Stock And Warrants Net-
Proceeds From Issuance Of Common Stock And Warrants-
Proceeds From Issuance Of Long Term Debt And Warrants-
Payment Of Deferred Offering Costs-
Proceeds From Conditional Economic Incentive-
Proceeds From Exercises Of Warrants And Stock Options-
Payments Of Deferred Offering Costs-0.44
Proceeds From Issuance Of Common Stock And Pre Funded Warrants In Public Offering Net-
Proceeds From Issuance Of Common Stock In Registered Direct Offering Net-
Proceeds From Payments For Share Based Compensation Net-
Payments Of Conditional Economic Incentive-
Proceeds From Issuance Of Common Stock And Pre Funded Warrants Direct Offering Net-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities206.84
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-67.55
Total Cash Flow6.83
4 historic quarters locked

Sign in to unlock the full Altimmune inc cash flow history.

Sign In Create Free Account

About Altimmune Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001326190-26-000018

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License